Urinary gonadotropin

This product is a sterile product extracted from the urine of menopausal women and refined by adding appropriate excipients and freeze-drying. It contains two biologically active ingredients, follicle-stimulating hormone and luteinizing hormone, with a ratio of about 1

Used in combination with chorionic gonadotropin, it is used for primary or secondary amenorrhea caused by insufficient gonadotropin secretion, infertility caused by anovulation, etc.

Dissolve in 1~2ml sterile water for injection for intramuscular injection. Initially (75~150u per time, once a day. After seven days, adjust the dose according to the patient's estrogen level and follicle development, and increase to 150~225u per day. After the follicles mature, inject 10,000u of human chorionic gonadotropin (HCG) intramuscularly to induce ovulation. If the ovaries do not respond three weeks after the injection, stop taking the drug.

The main symptom is ovarian hyperstimulation syndrome, which is characterized by lower abdominal discomfort or distension, abdominal pain, nausea, vomiting, and ovarian enlargement. Severe cases can cause chest tightness, shortness of breath, decreased urine output, pleural effusion, ascites, and even ruptured follicular cysts and bleeding. In addition, there are multiple pregnancies and premature births.

Keep in dark, airtight, and cool place

Qingdao Kangyuan Pharmaceutical Co., Ltd.

• Founded in:

  2001-08-18

• Address:

  Yinghai Industrial Park, Jiaozhou City, Qingdao

• Tax NO.:

  91370281614262275C

• Registered Funds:

  43.3 million yuan

• Website:

  Log in to view

• Email:

  Log in to view